by Truveta Research | Jun 13, 2025 | Research, Research Insights
Truveta and collaborators partnered on a new large-scale study that considers the potential benefits of GLP-1 RA for AUD, among those with diabetes and/or obesity. Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with...
by Truveta Research | May 14, 2025 | Research, Research Insights
Authors: Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD, PhD ⊕Truveta, Inc, Bellevue, WA Side effects were the most common...
by Truveta Research | May 14, 2025 | Research, Research Insights
Authors: Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD, PhD ⊕Truveta, Inc, Bellevue, WA Moderate adherence was observed for...
by Truveta staff | May 8, 2025 | News
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and...
by Truveta staff | Apr 15, 2025 | Research, Research Insights
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2017 and October 2024. During the early months of the COVID-19 pandemic, the rate of syphilis incidence (e.g., new infection) increased significantly, reaching a...